Details for: LSM6

Gene ID: 11157

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: LSM6

Ensembl ID: ENSG00000164167

Description: LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • intestinal epithelial cell CL0002563
    CSI 37.2
    rCSI 38.88%
    PRS 33.02
  • granulocyte monocyte progenitor cell CL0000557
    CSI 32.21
    rCSI 27.89%
    PRS 36.01
  • promonocyte CL0000559
    CSI 25.9
    rCSI 44.37%
    PRS 41.64
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 24.04
    rCSI 21.71%
    PRS 30
  • erythrocyte CL0000232
    CSI 22.95
    rCSI 52.07%
    PRS 39.33
  • common myeloid progenitor CL0000049
    CSI 20.24
    rCSI 16.36%
    PRS 32.88
  • promyelocyte CL0000836
    CSI 17.54
    rCSI 25.3%
    PRS 42.34
  • common dendritic progenitor CL0001029
    CSI 15.78
    rCSI 19.81%
    PRS 41.12
  • double negative thymocyte CL0002489
    CSI 15.57
    rCSI 10.82%
    PRS 39.29
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 14.19
    rCSI 18.59%
    PRS 44.52
  • fraction A pre-pro B cell CL0002045
    CSI 14.04
    rCSI 16.07%
    PRS 56.04
  • large pre-B-II cell CL0000957
    CSI 13.94
    rCSI 39.78%
    PRS 48.23
  • epithelial cell of lower respiratory tract CL0002632
    CSI 13.43
    rCSI 10.41%
    PRS 32.25
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 11.77
    rCSI 9.07%
    PRS 31.13
  • conventional dendritic cell CL0000990
    CSI 11.35
    rCSI 9.47%
    PRS 59.28
  • vascular associated smooth muscle cell CL0000359
    CSI 11.15
    rCSI 36.16%
    PRS 36.79
  • immature B cell CL0000816
    CSI 10.36
    rCSI 7.7%
    PRS 44.87
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 10.26
    rCSI 11.85%
    PRS 28.58
  • mucus secreting cell CL0000319
    CSI 10.07
    rCSI 15.99%
    PRS 41.46
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 9.88
    rCSI 18.69%
    PRS 57.45
  • ciliated cell CL0000064
    CSI 8.93
    rCSI 14.47%
    PRS 32.01
  • common lymphoid progenitor CL0000051
    CSI 7.97
    rCSI 10.66%
    PRS 54.76
  • stem cell CL0000034
    CSI 7.75
    rCSI 7.47%
    PRS 25.07
  • hematopoietic stem cell CL0000037
    CSI 7.6
    rCSI 5.05%
    PRS 36.96
  • lung pericyte CL0009089
    CSI 7.56
    rCSI 19.96%
    PRS 38.51
  • radial glial cell CL0000681
    CSI 6.97
    rCSI 9.68%
    PRS 32.82
  • astrocyte of the cerebral cortex CL0002605
    CSI 6.95
    rCSI 15.59%
    PRS 21.19
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 6.79
    rCSI 4.01%
    PRS 45.04
  • primitive red blood cell CL0002355
    CSI 6.68
    rCSI 36.04%
    PRS 48.07
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 6.54
    rCSI 18.76%
    PRS 47.7
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 6.12
    rCSI 10.82%
    PRS 19.97
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 5.82
    rCSI 5.38%
    PRS 52.61
  • pancreatic ductal cell CL0002079
    CSI 5.77
    rCSI 11.22%
    PRS 33.89
  • BEST4+ enteroycte CL4030026
    CSI 5.6
    rCSI 6.97%
    PRS 34.94
  • pulmonary ionocyte CL0017000
    CSI 5.44
    rCSI 6.63%
    PRS 39.43
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 5.42
    rCSI 4.12%
    PRS 42.24
  • CD4-positive helper T cell CL0000492
    CSI 5.24
    rCSI 3.97%
    PRS 43.52
  • transit amplifying cell of small intestine CL0009012
    CSI 5.2
    rCSI 22.85%
    PRS 52.76
  • transit amplifying cell of colon CL0009011
    CSI 4.98
    rCSI 5.85%
    PRS 36.24
  • early lymphoid progenitor CL0000936
    CSI 4.92
    rCSI 4.32%
    PRS 37.1
  • plasmablast CL0000980
    CSI 4.82
    rCSI 3.79%
    PRS 38.36
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 4.8
    rCSI 6.54%
    PRS 61.48
  • neural crest cell CL0011012
    CSI 4.68
    rCSI 3.7%
    PRS 23
  • memory T cell CL0000813
    CSI 4.68
    rCSI 9.01%
    PRS 62.76
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 4.52
    rCSI 23.32%
    PRS 56
  • megakaryocyte CL0000556
    CSI 4.45
    rCSI 19.31%
    PRS 49.28
  • type L enteroendocrine cell CL0002279
    CSI 4.32
    rCSI 8.1%
    PRS 53.78
  • erythroid progenitor cell CL0000038
    CSI 4.19
    rCSI 24.01%
    PRS 43.91
  • memory B cell CL0000787
    CSI 4.15
    rCSI 4.1%
    PRS 72.79
  • non-classical monocyte CL0000875
    CSI 4.13
    rCSI 6.62%
    PRS 64.01
  • germinal center B cell CL0000844
    CSI 4.1
    rCSI 12.22%
    PRS 58.02
  • myeloid leukocyte CL0000766
    CSI 4.02
    rCSI 3.71%
    PRS 33.75
  • pulmonary capillary endothelial cell CL4028001
    CSI 4
    rCSI 7.63%
    PRS 48.49
  • mononuclear phagocyte CL0000113
    CSI 3.99
    rCSI 8.79%
    PRS 36.34
  • T-helper 17 cell CL0000899
    CSI 3.93
    rCSI 3.12%
    PRS 53.26
  • interstitial cell of Cajal CL0002088
    CSI 3.91
    rCSI 4.97%
    PRS 37.3
  • perivascular cell CL4033054
    CSI 3.77
    rCSI 5.15%
    PRS 36.49
  • enterocyte CL0000584
    CSI 3.73
    rCSI 6.01%
    PRS 43.5
  • multi-ciliated epithelial cell CL0005012
    CSI 3.63
    rCSI 3.62%
    PRS 28.03
  • placental villous trophoblast CL2000060
    CSI 3.55
    rCSI 5.48%
    PRS 30.95
  • colonocyte CL1000347
    CSI 3.52
    rCSI 5.05%
    PRS 40.57
  • hematopoietic precursor cell CL0008001
    CSI 3.51
    rCSI 3.61%
    PRS 48.89
  • luminal cell of prostate epithelium CL0002340
    CSI 3.45
    rCSI 18.55%
    PRS 49.27
  • Langerhans cell CL0000453
    CSI 3.38
    rCSI 5.16%
    PRS 50.46
  • myofibroblast cell CL0000186
    CSI 3.27
    rCSI 4.52%
    PRS 39.67
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 3.26
    rCSI 3.2%
    PRS 46.9
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 3.25
    rCSI 7.4%
    PRS 32.29
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 3.18
    rCSI 2.55%
    PRS 53
  • epithelial cell of lung CL0000082
    CSI 3.13
    rCSI 2.59%
    PRS 31.11
  • pulmonary artery endothelial cell CL1001568
    CSI 3.09
    rCSI 4.2%
    PRS 45.14
  • naive T cell CL0000898
    CSI 3.07
    rCSI 2.13%
    PRS 44.06
  • pro-B cell CL0000826
    CSI 3.07
    rCSI 2.54%
    PRS 33.23
  • colon epithelial cell CL0011108
    CSI 3.07
    rCSI 3.21%
    PRS 30.49
  • elicited macrophage CL0000861
    CSI 3.03
    rCSI 2.78%
    PRS 38.62
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 3.02
    rCSI 3.87%
    PRS 31.19
  • M cell of gut CL0000682
    CSI 3
    rCSI 3.19%
    PRS 48.59
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.97
    rCSI 3.03%
    PRS 44.52
  • lung macrophage CL1001603
    CSI 2.96
    rCSI 6.61%
    PRS 37.97
  • alveolar macrophage CL0000583
    CSI 2.86
    rCSI 4.71%
    PRS 37.54
  • basal cell CL0000646
    CSI 2.85
    rCSI 3.82%
    PRS 34.55
  • alveolar adventitial fibroblast CL4028006
    CSI 2.85
    rCSI 4.5%
    PRS 33.22
  • intestine goblet cell CL0019031
    CSI 2.84
    rCSI 2.52%
    PRS 32.3
  • pancreatic A cell CL0000171
    CSI 2.84
    rCSI 2.98%
    PRS 34.59
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 2.8
    rCSI 8.27%
    PRS 37.25
  • pancreatic stellate cell CL0002410
    CSI 2.77
    rCSI 16.1%
    PRS 44.27
  • ciliated epithelial cell CL0000067
    CSI 2.71
    rCSI 2.38%
    PRS 24.2
  • mesodermal cell CL0000222
    CSI 2.7
    rCSI 3.25%
    PRS 31.47
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 2.69
    rCSI 3.25%
    PRS 38.97
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 2.68
    rCSI 1.92%
    PRS 43.57
  • blood vessel endothelial cell CL0000071
    CSI 2.65
    rCSI 5.51%
    PRS 31.82
  • myeloid dendritic cell CL0000782
    CSI 2.62
    rCSI 3.8%
    PRS 47.3
  • CD14-positive monocyte CL0001054
    CSI 2.6
    rCSI 3.23%
    PRS 43.32
  • goblet cell CL0000160
    CSI 2.58
    rCSI 2.44%
    PRS 33.82
  • pro-T cell CL0000827
    CSI 2.52
    rCSI 58.79%
    PRS 90.48
  • Kupffer cell CL0000091
    CSI 2.49
    rCSI 5.7%
    PRS 32.15
  • pancreatic acinar cell CL0002064
    CSI 2.46
    rCSI 3.27%
    PRS 36.12
  • keratinocyte CL0000312
    CSI 2.46
    rCSI 2.06%
    PRS 37.52
  • duct epithelial cell CL0000068
    CSI 2.46
    rCSI 3.59%
    PRS 34.79
  • myoepithelial cell CL0000185
    CSI 2.45
    rCSI 6.2%
    PRS 39.66
  • secretory cell CL0000151
    CSI 2.43
    rCSI 2.53%
    PRS 33.25
  • epithelial cell of urethra CL1000296
    CSI 0.1
    rCSI 3.6%
    PRS 64.0%
  • cytotoxic T cell CL0000910
    CSI 0.2
    rCSI 0.9%
    PRS 44.8%
  • hair follicular keratinocyte CL2000092
    CSI 0.2
    rCSI 3.1%
    PRS 73.4%
  • B-2 B cell CL0000822
    CSI 0.2
    rCSI 3.8%
    PRS 80.5%
  • amacrine cell CL0000561
    CSI 0.3
    rCSI 0.8%
    PRS 26.2%
  • Cajal-Retzius cell CL0000695
    CSI 0.3
    rCSI 2.3%
    PRS 52.2%
  • paneth cell of colon CL0009009
    CSI 0.3
    rCSI 3.0%
    PRS 61.6%
  • paneth cell CL0000510
    CSI 0.4
    rCSI 0.6%
    PRS 48.2%
  • type B pancreatic cell CL0000169
    CSI 0.4
    rCSI 0.9%
    PRS 30.3%
  • eosinophil CL0000771
    CSI 0.4
    rCSI 2.9%
    PRS 65.4%
  • endothelial cell of placenta CL0009092
    CSI 0.5
    rCSI 2.2%
    PRS 42.7%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.5
    rCSI 1.5%
    PRS 21.6%
  • type EC enteroendocrine cell CL0000577
    CSI 0.5
    rCSI 1.7%
    PRS 47.0%
  • chondrocyte CL0000138
    CSI 0.5
    rCSI 0.8%
    PRS 27.6%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 0.6
    rCSI 1.4%
    PRS 20.0%
  • pancreatic epsilon cell CL0005019
    CSI 0.6
    rCSI 2.8%
    PRS 57.8%
  • podocyte CL0000653
    CSI 0.6
    rCSI 2.8%
    PRS 31.5%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 0.6
    rCSI 2.8%
    PRS 72.2%
  • microcirculation associated smooth muscle cell CL0008035
    CSI 0.7
    rCSI 2.0%
    PRS 35.5%
  • mammary gland epithelial cell CL0002327
    CSI 0.8
    rCSI 2.8%
    PRS 49.3%
  • deuterosomal cell CL4033044
    CSI 0.8
    rCSI 2.7%
    PRS 44.2%
  • retinal cone cell CL0000573
    CSI 0.8
    rCSI 1.3%
    PRS 25.5%
  • colon macrophage CL0009038
    CSI 0.8
    rCSI 3.7%
    PRS 56.2%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 0.8
    rCSI 3.2%
    PRS 51.3%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 0.8
    rCSI 1.7%
    PRS 50.2%
  • forebrain radial glial cell CL0013000
    CSI 0.9
    rCSI 2.7%
    PRS 41.4%
  • primordial germ cell CL0000670
    CSI 0.9
    rCSI 4.3%
    PRS 79.6%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 0.9
    rCSI 2.1%
    PRS 48.5%
  • B-1 B cell CL0000819
    CSI 0.9
    rCSI 23.2%
    PRS 79.8%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 0.9
    rCSI 1.1%
    PRS 51.7%
  • basal cell of prostate epithelium CL0002341
    CSI 1.0
    rCSI 2.8%
    PRS 54.5%
  • thymocyte CL0000893
    CSI 1.0
    rCSI 3.5%
    PRS 71.9%
  • endothelial cell of uterus CL0009095
    CSI 1.0
    rCSI 7.1%
    PRS 63.1%
  • hepatocyte CL0000182
    CSI 1.0
    rCSI 1.8%
    PRS 30.9%
  • intermediate monocyte CL0002393
    CSI 1.0
    rCSI 1.5%
    PRS 33.8%
  • myelocyte CL0002193
    CSI 1.0
    rCSI 6.7%
    PRS 69.5%
  • cord blood hematopoietic stem cell CL2000095
    CSI 1.0
    rCSI 19.6%
    PRS 86.6%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 1.0
    rCSI 1.7%
    PRS 20.6%
  • intestinal tuft cell CL0019032
    CSI 1.1
    rCSI 1.7%
    PRS 36.8%
  • colon goblet cell CL0009039
    CSI 1.2
    rCSI 2.8%
    PRS 44.8%
  • cardiac endothelial cell CL0010008
    CSI 1.2
    rCSI 4.8%
    PRS 31.4%
  • cerebral cortex endothelial cell CL1001602
    CSI 1.2
    rCSI 2.1%
    PRS 25.4%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 1.2
    rCSI 3.1%
    PRS 25.5%
  • retinal rod cell CL0000604
    CSI 1.2
    rCSI 2.2%
    PRS 31.8%
  • foveolar cell of stomach CL0002179
    CSI 1.3
    rCSI 2.7%
    PRS 47.4%
  • club cell CL0000158
    CSI 1.3
    rCSI 1.8%
    PRS 34.4%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 1.3
    rCSI 7.6%
    PRS 59.4%
  • alternatively activated macrophage CL0000890
    CSI 1.3
    rCSI 1.6%
    PRS 45.7%
  • pre-conventional dendritic cell CL0002010
    CSI 1.3
    rCSI 16.8%
    PRS 68.7%
  • mucous neck cell CL0000651
    CSI 1.3
    rCSI 1.9%
    PRS 46.4%
  • granulocyte CL0000094
    CSI 1.3
    rCSI 2.0%
    PRS 40.9%
  • professional antigen presenting cell CL0000145
    CSI 1.3
    rCSI 4.6%
    PRS 68.4%
  • acinar cell CL0000622
    CSI 1.4
    rCSI 2.0%
    PRS 42.0%
  • respiratory suprabasal cell CL4033048
    CSI 1.4
    rCSI 1.8%
    PRS 37.1%
  • enteric smooth muscle cell CL0002504
    CSI 1.4
    rCSI 2.0%
    PRS 35.4%
  • respiratory hillock cell CL4030023
    CSI 1.4
    rCSI 2.5%
    PRS 48.4%
  • extravillous trophoblast CL0008036
    CSI 1.4
    rCSI 1.8%
    PRS 29.1%
  • class switched memory B cell CL0000972
    CSI 1.5
    rCSI 1.1%
    PRS 50.3%
  • ionocyte CL0005006
    CSI 1.5
    rCSI 1.6%
    PRS 30.5%
  • retina horizontal cell CL0000745
    CSI 1.5
    rCSI 2.3%
    PRS 30.3%
  • keratocyte CL0002363
    CSI 1.5
    rCSI 3.7%
    PRS 43.9%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 1.5
    rCSI 2.1%
    PRS 53.6%
  • glandular epithelial cell CL0000150
    CSI 1.6
    rCSI 4.1%
    PRS 55.6%
  • mature B cell CL0000785
    CSI 1.6
    rCSI 1.4%
    PRS 40.4%
  • lung ciliated cell CL1000271
    CSI 1.6
    rCSI 1.9%
    PRS 24.8%
  • rod bipolar cell CL0000751
    CSI 1.6
    rCSI 2.9%
    PRS 27.5%
  • neural progenitor cell CL0011020
    CSI 1.6
    rCSI 7.2%
    PRS 28.4%
  • Hofbauer cell CL3000001
    CSI 1.6
    rCSI 3.1%
    PRS 41.2%
  • conjunctival epithelial cell CL1000432
    CSI 1.7
    rCSI 2.5%
    PRS 33.0%
  • natural T-regulatory cell CL0000903
    CSI 1.7
    rCSI 3.1%
    PRS 68.8%
  • adventitial cell CL0002503
    CSI 1.7
    rCSI 4.1%
    PRS 44.4%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 1.7
    rCSI 1.1%
    PRS 40.7%
  • retinal bipolar neuron CL0000748
    CSI 1.7
    rCSI 3.2%
    PRS 24.7%
  • T follicular helper cell CL0002038
    CSI 1.8
    rCSI 1.3%
    PRS 46.7%
  • bronchus fibroblast of lung CL2000093
    CSI 1.8
    rCSI 1.4%
    PRS 33.6%
  • transit amplifying cell CL0009010
    CSI 1.8
    rCSI 2.7%
    PRS 48.8%
  • peripheral nervous system neuron CL2000032
    CSI 1.8
    rCSI 2.4%
    PRS 28.2%
  • pancreatic PP cell CL0002275
    CSI 1.8
    rCSI 7.1%
    PRS 48.9%
  • progenitor cell CL0011026
    CSI 1.8
    rCSI 3.8%
    PRS 40.7%
  • mesenchymal cell CL0008019
    CSI 1.8
    rCSI 4.6%
    PRS 30.8%
  • kidney epithelial cell CL0002518
    CSI 1.9
    rCSI 3.6%
    PRS 56.9%
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 1.9
    rCSI 1.7%
    PRS 46.9%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 1.9
    rCSI 3.0%
    PRS 60.2%
  • glioblast CL0000030
    CSI 2.0
    rCSI 3.1%
    PRS 27.9%
  • skin fibroblast CL0002620
    CSI 2.0
    rCSI 1.7%
    PRS 43.0%
  • dendritic cell CL0000451
    CSI 2.0
    rCSI 2.4%
    PRS 63.3%
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 2.0
    rCSI 2.0%
    PRS 64.5%
  • Bergmann glial cell CL0000644
    CSI 2.1
    rCSI 2.8%
    PRS 31.2%
  • mature T cell CL0002419
    CSI 2.1
    rCSI 1.6%
    PRS 47.1%
  • pluripotent stem cell CL0002248
    CSI 2.1
    rCSI 62.4%
    PRS 58.1%
  • small pre-B-II cell CL0000954
    CSI 2.1
    rCSI 2.0%
    PRS 57.0%
  • activated type II NK T cell CL0000931
    CSI 2.1
    rCSI 2.4%
    PRS 48.0%
  • group 3 innate lymphoid cell CL0001071
    CSI 2.1
    rCSI 1.6%
    PRS 35.1%
  • dendritic cell, human CL0001056
    CSI 2.1
    rCSI 3.3%
    PRS 38.4%
  • exhausted T cell CL0011025
    CSI 2.2
    rCSI 36.5%
    PRS 70.6%
  • alveolar type 1 fibroblast cell CL4028004
    CSI 2.2
    rCSI 2.4%
    PRS 36.2%
  • unswitched memory B cell CL0000970
    CSI 2.2
    rCSI 1.9%
    PRS 48.5%
  • enteroendocrine cell CL0000164
    CSI 2.3
    rCSI 3.1%
    PRS 35.3%
  • pancreatic D cell CL0000173
    CSI 2.3
    rCSI 2.2%
    PRS 34.8%
  • interneuron CL0000099
    CSI 2.3
    rCSI 4.6%
    PRS 24.7%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary Analyzed for its expression specificity (CSI Z-Score), **LSM6** is identified as a ubiquitously expressed gene, demonstrating a lack of cell-type specificity. This expression pattern is consistent with its fundamental role in essential, conserved cellular processes, including pre-mRNA splicing and mRNA decay. As a core component of the LSm protein complex, it is indispensable for the metabolism of RNA in virtually all cell types, positioning it as a classic housekeeping gene. ## Cellular Roles and Expression Landscape The expression profile of [LSM6](/details-gene/11157), when evaluated for specificity, underscores its role as a ubiquitous and constitutively expressed gene. The **Overall** analysis reveals a CSI (Z-SCORE) of 0.00 across a diverse array of cell types, including [intestinal epithelial cell](/details-cell/CL0002563), various hematopoietic progenitors like [granulocyte monocyte progenitor cell](/details-cell/CL0000557) and [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050), and mature cells such as [erythrocyte](/details-cell/CL0000232). This complete lack of specificity, further supported by statistically non-significant p-values (e.g., p-value > 0.1) and low percentile rank scores (PRS: 30-60%), indicates that [LSM6](/details-gene/11157) expression is not a distinguishing feature of any particular cell lineage. Instead, its consistent presence (Effect Size: 1.00) across these functionally and developmentally distinct cell populations suggests a conserved, essential function. The expression in both rapidly dividing progenitor cells and terminally differentiated cells highlights that its role is not confined to a specific cellular state but is integral to core cellular maintenance and function. ## Pathways and Molecular Function The broad expression of [LSM6](/details-gene/11157) is a direct reflection of its central role in fundamental RNA metabolism, as detailed by its functional annotations. [LSM6](/details-gene/11157) is a key component of the LSm2-8 and LSm1-7 complexes, which form doughnut-shaped structures that bind to RNA ([PubMed: 10369684](https://pubmed.ncbi.nlm.nih.gov/10369684/)). Its functional involvement is primarily in two critical pathways: * **mRNA Splicing:** As a component of the U6 snRNP, [LSM6](/details-gene/11157) is integral to the spliceosome, the machinery responsible for removing introns from pre-mRNA. This is supported by its association with pathways like '[mRNA splicing - major pathway](/details-pathway/R-HSA-72163)' and '[Processing of capped intron-containing pre-mrna](/details-pathway/R-HSA-72203)', and GO terms such as '[U4/u6 x u5 tri-snrnp complex](/details-go/GO:0046540)'. The LSm2-8 complex specifically binds the 3'-end of U6 snRNA, facilitating the assembly and catalytic activity of the spliceosome ([PubMed: 10523320](https://pubmed.ncbi.nlm.nih.gov/10523320/), [PubMed: 26912367](https://pubmed.ncbi.nlm.nih.gov/26912367/)). * **mRNA Decay:** The LSm1-7 complex, containing [LSM6](/details-gene/11157), localizes to cytoplasmic foci known as '[P-body](/details-go/GO:0000932)' structures ([PubMed: 12515382](https://pubmed.ncbi.nlm.nih.gov/12515382/)). In these bodies, it participates in mRNA degradation pathways, particularly '[Deadenylation-dependent mrna decay](/details-pathway/R-HSA-429914)', by promoting decapping and subsequent 5'-to-3' exonucleolytic decay. This dual role in both the creation of mature mRNA (splicing) and the regulation of its turnover (decay) firmly establishes [LSM6](/details-gene/11157) as a master regulator of the cellular transcriptome, explaining its essentiality and ubiquitous expression. ## Research Directions Given that [LSM6](/details-gene/11157) is a core housekeeping gene, research should focus on whether its expression levels, rather than its presence, are modulated in disease, and whether specific cell types exhibit unique dependencies on its function. **Testable Hypotheses:** 1. **Hypothesis:** Although ubiquitously expressed, rapidly proliferating cancer cells with high transcriptional loads may be hypersensitive to subtle perturbations in [LSM6](/details-gene/11157) levels, creating a therapeutic vulnerability. It is hypothesized that partial inhibition of [LSM6](/details-gene/11157) will disproportionately affect the viability and splicing fidelity of cancer cells compared to quiescent, non-malignant cells. * **Experimental Approach:** Utilize siRNA or shRNA to titrate [LSM6](/details-gene/11157) knockdown in a panel of cancer cell lines versus primary differentiated cells. Assess cell viability with proliferation assays and analyze global splicing patterns using high-throughput RNA sequencing to identify cancer-specific splicing defects. 2. **Hypothesis:** The role of [LSM6](/details-gene/11157) in P-bodies suggests its function is critical for managing the cellular transcriptome during stress. It is hypothesized that cells deficient in [LSM6](/details-gene/11157) will fail to properly sequester or degrade mRNAs in response to cellular stressors like viral infection or oxidative stress, leading to increased cell death. * **Experimental Approach:** Generate [LSM6](/details-gene/11157) knockout or knockdown cells using CRISPR/Cas9 or RNAi. Expose these cells and wild-type controls to stressors such as sodium arsenite (oxidative stress) or poly(I:C) (viral mimic). Use immunofluorescence to quantify P-body formation and qRT-PCR to measure the half-life of known stress-responsive transcripts. 3. **Hypothesis:** While expressed broadly, specific developmental transitions that require extensive transcriptomic reprogramming, such as hematopoietic differentiation, may rely on dynamic post-translational modifications of the LSm complex to fine-tune its activity. It is hypothesized that acetylation of the LSm complex, as previously reported ([PubMed: 19608861](https://pubmed.ncbi.nlm.nih.gov/19608861/)), modulates its affinity for specific RNA targets during myeloid or lymphoid differentiation. * **Experimental Approach:** Differentiate hematopoietic stem cells (HSCs) in vitro. Perform immunoprecipitation of [LSM6](/details-gene/11157) at different stages of differentiation followed by mass spectrometry to map dynamic post-translational modifications. Use site-directed mutagenesis to create modification-deficient [LSM6](/details-gene/11157) variants and assess their impact on differentiation efficiency and target RNA binding via RNA immunoprecipitation (RIP-seq). **Therapeutic Potential:** Direct targeting of [LSM6](/details-gene/11157) is likely to induce significant systemic toxicity due to its essential housekeeping function. However, it may represent an attractive *indirect* therapeutic target. Malignancies characterized by high rates of transcription or mutations in other spliceosome components (e.g., myelodysplastic syndromes) may exhibit "spliceosome addiction." In these contexts, developing small molecules that subtly modulate the activity of the LSm complex, rather than ablating it, could offer a therapeutic window by selectively targeting the heightened dependency of cancer cells on RNA processing.

Genular Protein ID: 2381384963

Symbol: LSM6_HUMAN

Name: U6 snRNA-associated Sm-like protein LSm6

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 10369684

Title: Sm and Sm-like proteins assemble in two related complexes of deep evolutionary origin.

PubMed ID: 10369684

DOI: 10.1093/emboj/18.12.3451

PubMed ID: 10523320

Title: A doughnut-shaped heteromer of human Sm-like proteins binds to the 3'-end of U6 snRNA, thereby facilitating U4/U6 duplex formation in vitro.

PubMed ID: 10523320

DOI: 10.1093/emboj/18.20.5789

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 15815621

Title: Generation and annotation of the DNA sequences of human chromosomes 2 and 4.

PubMed ID: 15815621

DOI: 10.1038/nature03466

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 12515382

Title: The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci.

PubMed ID: 12515382

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 26912367

Title: Molecular architecture of the human U4/U6.U5 tri-snRNP.

PubMed ID: 26912367

DOI: 10.1126/science.aad2085

PubMed ID: 28781166

Title: Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for Activation.

PubMed ID: 28781166

DOI: 10.1016/j.cell.2017.07.011

Sequence Information:

  • Length: 80
  • Mass: 9128
  • Checksum: 21167891FDE804F1
  • Sequence:
  • MSLRKQTPSD FLKQIIGRPV VVKLNSGVDY RGVLACLDGY MNIALEQTEE YVNGQLKNKY 
    GDAFIRGNNV LYISTQKRRM